UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000022535
Receipt number R000025919
Scientific Title A phase II study for the safety and efficacy of TAS-102 and Bevacizumab for patients with unresectable colorectal cancer considering Oxaliplatin to stop and go.
Date of disclosure of the study information 2016/05/31
Last modified on 2018/01/25 23:15:49

No. Disposal Last modified on Item of update
1 Insert 2016/05/30 17:54:14
2 Update 2016/06/20 08:29:27 Acronym
Acronym
3 Update 2017/05/31 10:39:04 Recruitment status
4 Update 2017/05/31 10:40:00 Email1
5 Update 2018/01/25 23:15:49 Recruitment status
Date analysis concluded